| Schedule of Reserved Shares of Common Stock |
The Company had reserved shares of common stock for issuance in connection with the following, as of the below periods: | | | As of
June 30,
2026 | | As of
December 31,
2025 | | Conversion of Series Seed-1 | | 1,536,006 | | 1,536,006 | | Conversion of Series Seed-2 | | 1,099,412 | | 1,099,412 | | Conversion of Series A-1 | | 1,059,058 | | 1,059,058 | | Conversion of Series A | | 2,652,734 | | 2,652,734 | | Conversion of Series SA-2 | | 1,745,625 | | 1,745,625 | | Conversion of Series A-2 | | 3,184,572 | | 3,184,572 | | Conversion of Series X | | 779,240 | | 769,114 | | Exercise of stock options | | 3,256,084 | | 3,307,849 | | Common stock reserved for issuance | | 15,312,731 | | 15,354,370 |
|
The Company had reserved shares of common stock for issuance in connection with the following, as of the below periods: | | | As of December 31, | | | | 2025 | | 2024 | | Conversion of Series Seed-1 | | 1,536,006 | | 1,536,006 | | Conversion of Series Seed-2 | | 1,099,412 | | 1,099,412 | | Conversion of Series A-1 | | 1,059,058 | | 1,059,058 | | Conversion of Series A | | 2,652,734 | | 2,652,734 | | Conversion of Series SA-2 | | 1,745,625 | | 1,745,625 | | Conversion of Series A-2 | | 3,184,572 | | 1,773,460 | | Conversion of Series X | | 769,114 | | — | | Exercise of stock options authorized | | 3,307,849 | | 1,617,266 | | Common stock reserved for issuance | | 15,354,370 | | 11,483,561 |
|